• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用缺陷感染性单周期疱疹病毒在鳞状细胞癌中转移多个免疫调节基因的联合基因治疗。

Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.

作者信息

Kim S H, Carew J F, Kooby D A, Shields J, Entwisle C, Patel S, Shah J P, Fong Y

机构信息

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Cancer Gene Ther. 2000 Sep;7(9):1279-85. doi: 10.1038/sj.cgt.7700231.

DOI:10.1038/sj.cgt.7700231
PMID:11023201
Abstract

Herpes simplex type 2-defective infectious single-cycle (DISC) viruses are attenuated viruses that were originally produced as viral vaccines; however, these viruses are also efficient gene transfer vehicles. The main goals of this study were to examine determinants of the gene transfer by using DISC virus for squamous cancer and to evaluate the antitumoral efficacy of vaccination with tumor cells modified by DISC viruses carrying a combination of immunomodulatory genes (interleukin-2 (IL-2), granulocyte-macrophage colony-stimulating factor (GM-CSF), B7-1) in a model of squamous cell cancer (SCCVII) in C3H/HeJ mice. SCCVII cells transduced by DISC viruses (multiplicity of infection of 10) carrying the IL-2 or GM-CSF gene produced nanogram quantities of IL-2 or GM-CSF per 10(6) cells. Irradiated (5,000 cGy, 10,000 cGy) cells secreted levels of GM-CSF or IL-2 that were comparable with nonirradiated cells. In vivo vaccination using tumor cells transduced ex vivo with DISC-IL2 or DISC-GMCSF resulted in protection against subsequent tumor challenge (P < .01), with DISC-GMCSF-transduced, irradiated tumor cells showing the greatest effects (P < .001). Marked growth arrest also was noted in established tumors after direct injection of DISC-GMCSF (P < .001). These data demonstrate that (a) DISC virus is capable of efficient gene transfer, (b) GM-CSF-secreting genetically modified tumor vaccine protects against tumor cell challenge and suppresses tumor growth, and (c) intratumoral injection of DISC-GMCSF significantly suppresses the growth of established tumors. These results not only confirm clinically relevant gene transfer but also demonstrate that the gene transfer is an effective anti-cancer therapy.

摘要

2型单纯疱疹病毒缺陷感染单周期(DISC)病毒是减毒病毒,最初作为病毒疫苗生产;然而,这些病毒也是高效的基因传递载体。本研究的主要目的是通过使用DISC病毒研究鳞状细胞癌基因传递的决定因素,并在C3H/HeJ小鼠的鳞状细胞癌(SCCVII)模型中评估用携带免疫调节基因组合(白细胞介素-2(IL-2)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、B7-1)的DISC病毒修饰的肿瘤细胞进行疫苗接种的抗肿瘤效果。携带IL-2或GM-CSF基因的DISC病毒(感染复数为10)转导的SCCVII细胞每10⁶个细胞产生纳克量的IL-2或GM-CSF。经辐照(5000 cGy、10000 cGy)的细胞分泌的GM-CSF或IL-2水平与未辐照细胞相当。使用经DISC-IL2或DISC-GMCSF体外转导的肿瘤细胞进行体内疫苗接种可预防随后的肿瘤攻击(P <.01),其中经DISC-GMCSF转导、辐照的肿瘤细胞效果最佳(P <.001)。直接注射DISC-GMCSF后,在已形成的肿瘤中也观察到明显的生长停滞(P <.001)。这些数据表明:(a)DISC病毒能够进行高效的基因传递;(b)分泌GM-CSF的基因修饰肿瘤疫苗可预防肿瘤细胞攻击并抑制肿瘤生长;(c)瘤内注射DISC-GMCSF可显著抑制已形成肿瘤的生长。这些结果不仅证实了临床相关的基因传递,还表明基因传递是一种有效的抗癌疗法。

相似文献

1
Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.使用缺陷感染性单周期疱疹病毒在鳞状细胞癌中转移多个免疫调节基因的联合基因治疗。
Cancer Gene Ther. 2000 Sep;7(9):1279-85. doi: 10.1038/sj.cgt.7700231.
2
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.使用失活的感染性单周期单纯疱疹病毒载体转导细胞因子基因的“全”细胞疫苗用于预防和治疗的临床前评估。
Cancer Res. 2000 Mar 15;60(6):1663-70.
3
Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.粒细胞-巨噬细胞集落刺激因子和白细胞介素-6细胞基因修饰的自体肿瘤疫苗对小鼠肾细胞癌的抗肿瘤作用
J Immunother. 2001 May-Jun;24(3):205-11.
4
The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.细胞因子基因共转导对使用表达肿瘤相关抗原的基因修饰树突状细胞进行癌症疫苗治疗的增强作用。
Int J Oncol. 2006 Apr;28(4):947-53.
5
Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.表达粒细胞巨噬细胞集落刺激因子和B7.1的基因工程化胶质瘤细胞诱导大鼠T细胞凋亡
Clin Cancer Res. 2005 Feb 15;11(4):1639-49. doi: 10.1158/1078-0432.CCR-04-1366.
6
Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.失活感染性单周期单纯疱疹病毒(DISC-HSV)是一种用于在人类前列腺癌治疗中进行基因递送/表达GM-CSF的候选载体系统。
Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207.
7
Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.用于癌症基因免疫治疗的粒细胞巨噬细胞集落刺激因子与白细胞介素-2融合cDNA
Cancer Res. 2004 Dec 15;64(24):8795-9. doi: 10.1158/0008-5472.CAN-04-1776.
8
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.通过瘤内接种表达粒细胞巨噬细胞集落刺激因子的缺陷型单纯疱疹病毒载体抑制肿瘤生长。
Mol Ther. 2000 Oct;2(4):324-9. doi: 10.1006/mthe.2000.0130.
9
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.在溶瘤单纯疱疹病毒背景下可溶性B7-1的原位表达可诱导强大的抗肿瘤免疫。
Cancer Res. 2001 Jan 1;61(1):153-61.
10
Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.多种单纯疱疹病毒载体对肿瘤的高效共转导:对肿瘤疫苗生产的启示
Cancer Gene Ther. 2000 Apr;7(4):581-8. doi: 10.1038/sj.cgt.7700135.

引用本文的文献

1
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials.溶瘤病毒与免疫检查点抑制剂:从临床前研发到临床试验
Int J Mol Sci. 2020 Nov 16;21(22):8627. doi: 10.3390/ijms21228627.
2
An Oncolytic Vaccinia Virus Armed with GM-CSF and IL-24 Double Genes for Cancer Targeted Therapy.一种携带GM-CSF和IL-24双基因的溶瘤痘苗病毒用于癌症靶向治疗。
Onco Targets Ther. 2020 Apr 28;13:3535-3544. doi: 10.2147/OTT.S249816. eCollection 2020.
3
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds.
溶瘤病毒与免疫检查点抑制:两全其美
Mol Ther Oncolytics. 2019 Apr 25;13:93-106. doi: 10.1016/j.omto.2019.04.003. eCollection 2019 Jun 28.
4
Comparative antitumor effect of preventive versus therapeutic vaccines employing B16 melanoma cells genetically modified to express GM-CSF and B7.2 in a murine model.用表达 GM-CSF 和 B7.2 的 B16 黑色素瘤细胞对预防性和治疗性疫苗在小鼠模型中的抗肿瘤作用进行比较。
Toxins (Basel). 2012 Oct 31;4(11):1058-81. doi: 10.3390/toxins4111058.
5
Bead-selected antitumor genetic cell vaccines.磁珠分选抗肿瘤基因细胞疫苗
Clin Med Oncol. 2008;2:257-65. doi: 10.4137/cmo.s586. Epub 2008 Mar 25.
6
Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.用于肿瘤治疗的放射性核素标记的1型单纯疱疹病毒突变体的可行性。
World J Gastroenterol. 2008 Mar 7;14(9):1321-5. doi: 10.3748/wjg.14.1321.
7
Use of an oncolytic virus secreting GM-CSF as combined oncolytic and immunotherapy for treatment of colorectal and hepatic adenocarcinomas.使用分泌GM-CSF的溶瘤病毒作为联合溶瘤和免疫疗法治疗结直肠癌和肝腺癌。
Surgery. 2007 Apr;141(4):520-9. doi: 10.1016/j.surg.2006.10.010. Epub 2007 Feb 14.